Chaudhry V, Nittala M, Prasad M L
Lutheran General Hospital, Park Ridge, Illinois, USA.
Am Surg. 2000 Apr;66(4):387-93.
Our objective was to determine clinical outcomes of treatment of low rectal adenocarcinoma with neoadjuvant chemoradiation, rectal excision, and coloanal J pouch reconstruction. A retrospective review of 69 patients with stage B2 or higher lesions was performed. Preoperative chemoradiation was followed by low anterior resection and coloanal J pouch anastomosis, with end loop ileostomy. Data were analyzed using the SPSS computer software. There were 46 males and 23 females, with a median age of 63 years. Pathologic staging showed no tumor in the specimen, i.e.: stage 0, 14 per cent; stage A, 14 per cent; stage B, 53 per cent; stage C, 18 per cent; and stage D, 1.4 per cent. Postoperative mortality was 2.8 per cent, and the pelvic leak rate was 4.3 per cent. After curative resection, 89 per cent patients are alive and 83 per cent are disease free with a mean follow-up of 50 months. The local recurrence rate is 7.2 per cent. Nodal status was the most important predictor of survival and disease-free survival. Most (96%) have fewer than two bowel movements a day and are satisfied with the functional results. We conclude that preoperative chemoradiation and coloanal J pouch reconstruction can achieve low recurrence rates and prolonged survival for most patients with low rectal cancer with an acceptable quality of life.
我们的目的是确定新辅助放化疗、直肠切除及结肠肛管J形贮袋重建术治疗低位直肠腺癌的临床疗效。对69例B2期及以上病变患者进行了回顾性研究。术前进行放化疗,随后行低位前切除术及结肠肛管J形贮袋吻合术,并留置袢式回肠造口。使用SPSS计算机软件进行数据分析。患者中男性46例,女性23例,中位年龄63岁。病理分期显示标本中无肿瘤,即:0期占14%;A期占14%;B期占53%;C期占18%;D期占1.4%。术后死亡率为2.8%,盆腔渗漏率为4.3%。根治性切除术后,89%的患者存活,83%的患者无疾病,平均随访50个月。局部复发率为7.2%。淋巴结状态是生存和无病生存的最重要预测因素。大多数患者(96%)每天排便少于两次,对功能结果满意。我们得出结论,术前放化疗及结肠肛管J形贮袋重建术可使大多数低位直肠癌患者获得较低的复发率和较长的生存期,且生活质量可接受。